tirzepatide
Showing 1 - 25 of 49
Healthy Trial in Las Vegas (Tirzepatide)
Not yet recruiting
- Healthy
- Tirzepatide
-
Las Vegas, NevadaLas Vegas Clinical Research Unit - PPD
Jul 31, 2023
Obesity, Overweight and Obesity, Overweight Trial (Tirzepatide)
Not yet recruiting
- Obesity
- +2 more
- Tirzepatide
- (no location specified)
Jun 21, 2023
Obesity, Metabolic Disease Trial in Santa Barbara (Standard Care, Culturally-tailored dietary and behavioral intensive lifestyle
Not yet recruiting
- Obesity
- Metabolic Disease
- Standard Care
- +3 more
-
Santa Barbara, CaliforniaSansum Diabetes Research Institute
Aug 19, 2023
Healthy Trial in South Miami, San Antonio, Salt Lake City (Tirzepatide, Test, Reference)
Recruiting
- Healthy
- Tirzepatide
- +2 more
-
South Miami, Florida
- +2 more
Apr 14, 2023
Type II Diabetes, Atherosclerosis Trial in Torrance (Tirzepatide, Placebo)
Not yet recruiting
- Type II Diabetes
- Atherosclerosis
- Tirzepatide
- Placebo
-
Torrance, CaliforniaLundquist Institute for Biomedical Innovation at Harbor UCLA Med
Jan 24, 2023
Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)
Not yet recruiting
- Type 2 Diabetes
- Diabetes Mellitus, Type 2
- Tirzepatide
- (no location specified)
Feb 6, 2023
Obesity Trial in Atlanta, Oklahoma City (Tirzepatide, Placebo)
Not yet recruiting
- Obesity
- Tirzepatide
- Placebo
-
Atlanta, Georgia
- +1 more
Jan 17, 2023
Wolfram Syndrome Trial (Tirzepatide)
Not yet recruiting
- Wolfram Syndrome
- Tirzepatide
- (no location specified)
Dec 12, 2022
Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)
Recruiting
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Sep 21, 2022
Obesity Trial in Baton Rouge (Tirzepatide, Placebo)
Completed
- Obesity
- Tirzepatide
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Aug 1, 2022
Overweight, Obesity Trial in United States (Tirzepatide, Placebo)
Not yet recruiting
- Overweight
- Obesity
- Tirzepatide
- Placebo
-
Pelham, Alabama
- +19 more
Sep 14, 2023
Overweight, Obesity Trial in Daytona Beach (LY3457263, Tirzepatide, Placebo)
Recruiting
- Overweight
- Obesity
- LY3457263
- +2 more
-
Daytona Beach, FloridaLabCorp CRU, Inc.
Dec 8, 2022
Type 2 Diabetes Trial in China (Tirzepatide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Placebo
-
Beijing, Beijing, China
- +29 more
Jul 19, 2023
Diabetes, Type 2, Hypoglycemia Trial in Graz (Tirzepatide, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Hypoglycemia
- Tirzepatide
- Placebo
-
Graz, Steiermark, AustriaUniversitätsklinikum Graz
Feb 24, 2022
Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)
Not yet recruiting
- Obesity
- Overweight
- Tirzepatide
- Placebo
-
Decatur, Georgia
- +35 more
Oct 11, 2023
Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)
Recruiting
- Obesity
- Overweight
- Tirzepatide
- Semaglutide 2.4 mg
-
Birmingham, Alabama
- +31 more
Apr 26, 2023
Obesity, Overweight, Metabolism and Nutrition Disorder Trial in China (Tirzepatide, Placebo)
Completed
- Obesity
- +2 more
- Tirzepatide
- Placebo
-
Beijing, Beijing, China
- +28 more
Jan 18, 2023
Diabetes Type 2, Diabetes, Glucose Metabolism Disorders Trial in China (Tirzepatide, Placebo)
Not yet recruiting
- Diabetes Type 2
- +4 more
- Tirzepatide
- Placebo
-
Hefei, Anhui, China
- +28 more
Jan 11, 2023
Type 2 Diabetes, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- Obesity
- Tirzepatide
- Placebo
-
Caba, Buenos Aires, Argentina
- +48 more
Sep 8, 2023
Overweight, Obesity, Chronic Kidney Disease Trial in Worldwide (Tirzepatide, Placebo)
Not yet recruiting
- Overweight
- +4 more
- Tirzepatide
- Placebo
-
Northridge, California
- +25 more
Sep 9, 2022
Diabetes, Type 2 Trial in Cheng Du, Beijing (Tirzepatide, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Tirzepatide
- Placebo
-
Cheng Du, Sichuan, China
- +1 more
Aug 23, 2021
Obesity Trial in Japan (Tirzepatide, Placebo)
Active, not recruiting
- Obesity
- Tirzepatide
- Placebo
-
Ichikawa, Chiba, Japan
- +17 more
Feb 4, 2022
Type 2 Diabetes Trial in Japan (Tirzepatide, Oral antihyperglycemic medication (OAM))
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Oral antihyperglycemic medication (OAM)
-
Chiba-shi, Chiba, Japan
- +33 more
Jan 21, 2022